accountChinese and foreign pharmaceutical companies.' Dr. Colin Goddard, Chief Executive Officer of OSI Pharmaceuticals added, 'As a leading Chinese pharmaceutical company with a successful track record of developing and commercializing oncology products in...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals --Simcere to Develop, Manufacture and Market KDR/Kit inhibitor in China
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
